At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
BK4583 Monkeypox Concept
Closed 08-10 16:00:00 EDT
1,904.65
-4.02
-0.21%
High1,924.63Low1,887.46Vol31.27M
Open1,917.53D1 Closing1,908.67Amplitude1.95%
Mkt Cap0.00Tradable Cap0.00Total Shares0.00
T/O1.37BT/O Rate--Tradable Shares0.00
P/B6.070394ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Inovio Pharmaceuticals Inc Expected to Post a Loss of 22 Cents a Share - Earnings Preview
Reuters  ·  05:32
Inovio Pharmaceuticals Inc Expected to Post a Loss of 22 Cents a Share - Earnings Preview
Tonix Pharmaceuticals Holding Corp. Reports Results for the Quarter Ended June 30 - Earnings Summary
Reuters  ·  08-10 21:31
Tonix Pharmaceuticals Holding Corp. Reports Results for the Quarter Ended June 30 - Earnings Summary
Global Drugmakers Invest Billions to Boost US Presence
Reuters  ·  08-10 21:16
Global Drugmakers Invest Billions to Boost US Presence
Erasca Appoints Charles Fuchs as President of R&D
Reuters  ·  08-10 20:07
Erasca Appoints Charles Fuchs as President of R&D
Tonix Q2 Revenue Rises Sharply on Tonmya Launch
Reuters  ·  08-10 19:11
Tonix Q2 Revenue Rises Sharply on Tonmya Launch
Tonix Q2 FY26 Net Loss Narrows to $40.55 Million; Product Revenue Rises to $13.54 Million
Reuters  ·  08-10 19:03
Tonix Q2 FY26 Net Loss Narrows to $40.55 Million; Product Revenue Rises to $13.54 Million
Tonix Pharmaceuticals Reports Second Quarter 2026 Financial Results and Operational Highlights
THOMSON REUTERS  ·  08-10 19:00
Tonix Pharmaceuticals Reports Second Quarter 2026 Financial Results and Operational Highlights
Tonix Pharmaceuticals Q2 Net Income USD -40.552 Million
THOMSON REUTERS  ·  08-10 19:00
Tonix Pharmaceuticals Q2 Net Income USD -40.552 Million
Emergent Biosolutions is Maintained at Buy by HC Wainwright & Co.
Dow Jones  ·  08-10 18:22
Emergent Biosolutions is Maintained at Buy by HC Wainwright & Co.
Why Viatris (VTRS) Is Down 6.4% After Boosting Guidance And Completing A $1.15 Billion Buyback
Simply Wall St.  ·  08-10 16:24
Why Viatris (VTRS) Is Down 6.4% After Boosting Guidance And Completing A $1.15 Billion Buyback
Gilead: Strong HIV and Oncology Growth Underpins Reiterated Buy Rating and Unchanged $165 Price Target
TIPRANKS  ·  08-08
Gilead: Strong HIV and Oncology Growth Underpins Reiterated Buy Rating and Unchanged $165 Price Target
Gilead Sciences Inc. Stock Outperforms Competitors on Strong Trading Day
Dow Jones  ·  08-08
Gilead Sciences Inc. Stock Outperforms Competitors on Strong Trading Day
Moderna Inc. Stock Climbs 9.9%, Outperforms Peers
Dow Jones  ·  08-08
Moderna Inc. Stock Climbs 9.9%, Outperforms Peers
aTyr Pharma Q2 Net Loss Narrows
Reuters  ·  08-08
aTyr Pharma Q2 Net Loss Narrows
Tonix Pharmaceuticals Holding Corp. Expected to Post a Loss of $2.70 a Share - Earnings Preview
Reuters  ·  08-08
Tonix Pharmaceuticals Holding Corp. Expected to Post a Loss of $2.70 a Share - Earnings Preview
SIGA Publishes Investor Presentation on TPOXX Smallpox Antiviral Franchise and Growth Strategy
Reuters  ·  08-07
SIGA Publishes Investor Presentation on TPOXX Smallpox Antiviral Franchise and Growth Strategy
Analysts Offer Insights on Healthcare Companies: Viatris (VTRS), Immunocore Holdings (IMCR) and Praxis Precision Medicines (PRAX)
TIPRANKS  ·  08-07
Analysts Offer Insights on Healthcare Companies: Viatris (VTRS), Immunocore Holdings (IMCR) and Praxis Precision Medicines (PRAX)
Analysts Offer Insights on Healthcare Companies: Warby Parker (WRBY), Viatris (VTRS) and Fisher & Paykel Healthcare Corporation Limited (OtherFSPKF)
TIPRANKS  ·  08-07
Analysts Offer Insights on Healthcare Companies: Warby Parker (WRBY), Viatris (VTRS) and Fisher & Paykel Healthcare Corporation Limited (OtherFSPKF)
Quest Diagnostics Inc. Stock Outperforms Competitors on Strong Trading Day
Dow Jones  ·  08-07
Quest Diagnostics Inc. Stock Outperforms Competitors on Strong Trading Day
Moderna Inc. Stock Sheds 4.3%, Underperforms Peers
Dow Jones  ·  08-07
Moderna Inc. Stock Sheds 4.3%, Underperforms Peers

Introduction

Company Name.
BK4583
Affiliated Markets:
Listing Date:
--
Main Business:
Issue price:
--